TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06174103: BiVACOR® Total Artificial Heart Early Feasibility Study

Sponsor: BiVACOR Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$6,905,600

Rescue Site Savings

+$4,548,400

Unlock Full NCT06174103 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06174103 Rescue Dossier →